FDA clears Revive Therapeutics' Covid-19 trial of Bucillamine

August 3, 2020August 3, 2020 THE COVID REMEDY studies

Bucillamine is indicated to treat rheumatoid arthritis in Japan and South Korea. In Covid-19 patients, the drug is expected to increase glutathione activity …

Source: FDA clears Revive Therapeutics' Covid-19 trial of Bucillamine